Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: A Gynecologic Oncology Group study

Gynecologic Oncology

Volumn 103, Issue 3, 2006, Pages 853-858

  Waggoner, Steven E ^a   Darcy, Kathleen M ^b   Fuhrman, Barbara ^b   Parham, Groesbeck ^c   Lucci III, Joseph ^d   Monk, Bradley J ^e   Moore, David H ^f  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF ARKANSAS   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical carcinoma; Prognosis; Smoking; Urine cotinine concentration

Indexed keywords

CISPLATIN; COTININE; FLUOROURACIL;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS, PHASE III; COMBINED MODALITY THERAPY; COTININE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; NEOPLASM METASTASIS; NEOPLASM STAGING; PREVALENCE; PROGNOSIS; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SMOKING; SURVIVAL ANALYSIS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 33751414313     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.05.017     Document Type: Article

References (23)

1. Eifel P.J., Jhingran A., Bodurka D.C., Levenback C., and Thames H. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol 20 17 (2002) 3651-3657
2. Peters R.K., Thomas D., Hagan D.G., Mack T.M., and Henderson B.E. Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County. J Natl Cancer Inst 77 5 (1986) 1063-1077
3. Centers for Disease Control and Prevention. Women and smoking: a report of the surgeon general (executive summary). MMWR 51 RR-12 (2002) 1-13
4. Winkelstein W. Smoking and cancer of the uterine cervix: hypothesis. Am J Epidemiol 106 4 (1977) 257-259
5. Plummer M., Herrero R., Franceschi S., et al. Smoking and cervical cancer: pooled analysis of the IARC multi-centre case-control study. Cancer Causes Control 14 9 (2003) 805-814
6. Castle P.E., Wacholder S., Lorincz A.T., et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 94 18 (2002) 1406-1414
7. Tobacco smoke and involuntary smoking. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monogr Eval Carcinog Risks Hum 83 (2004) 1-1438
8. Kucera H., Enzelsberger H., Eppel W., and Weghaupt K. The influence of nicotine abuse and diabetes mellitus on the results of primary irradiation in the treatment of carcinoma of the cervix. Cancer 60 1 (1987) 1-4
9. Fyles A., Voduc D., Syed A., Milosevic M., Pintilie M., and Hill R. The effect of smoking on tumour oxygenation and treatment outcome in cervical cancer. J Clin Oncol 14 6 (2002) 442-446
10. Serur E., Fruchter R.G., Maiman M., McGuire J., Arrastia C.D., and Gibbon D. Age, substance abuse, and survival of patients with cervical carcinoma. Cancer 75 10 (1995) 2530-2538
11. Lanciano R., Calkins A., Bundy B.N., et al. A randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a Gynecologic Oncology Group Study. J Clin Oncol 23 33 (2005) 8289-8295
12. http://www.cdc.gov/nchs/about/major/nhis/hisdesgn.htm.
13. Donnelly N.J., Ward J.E., and Dalrymple C. Validation of women's self-reported smoking status in a Sydney colposcopy clinic. Aust N Z J Obstet Gynaecol 40 1 (2000) 74-77
14. Ferson M., Edwards A., Lind A., Milton G.W., and Hersey P. Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer 23 (1979) 603-609
15. Chalmer J., Holt P., and Keast D. Cell-mediated immune responses to transplanted tumors in mice chronically exposed to cigarette smoke. J NCI 55 (1975) 1129-1134
16. Jensen J.A., Goodson W.H., Hopf H.W., and Hunt T.K. Cigarette smoking decreases tissue oxygen. Arch Surg 126 9 (1991) 1131-1134
17. Wald N.J., Idle M., Boreham J., and Bailey A. Carbon monoxide in breath in relation to smoking and carboxyhaemoglobin levels. Thorax 36 5 (1981) 366-369
18. Hockel M., Schlenger K., Aral B., Mitze M., Schaffer U., and Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56 19 (1996) 4509-4515
19. Marteau T.M., Hankins M., and Collins B. Perceptions of risk of cervical cancer and attitudes towards cervical screening: a comparison of smokers and non-smokers. Fam Pract 19 1 (2002) 18-22
20. Rakowski W., Clark M.A., and Ehrich B. Smoking and cancer screening for women ages 42-75: associations in the 1990-1994 National Health Interview Surveys. Prev Med 29 (1999) 487-495
21. Daniell H.W. More advanced colonic cancer among smokers. Cancer 58 3 (1986) 784-787
22. Daniell H.W., Tam E., and Filice A. Larger axillary metastases in obese women and smokers with breast cancer-an influence by host factors on early tumor behavior. Breast Cancer Res Treat 25 3 (1993) 193-201
23. Hinds M.W., Yang H.Y., Stemmermann G., Lee J., and Kolonel L.N. Smoking history and lung cancer survival in women. J Natl Cancer Inst 68 3 (1982) 395-399